US EditionPublished • loading... • Updated
Diabetes Drugs Might Counter Brain Decline In Early Alzheimer's Patients
- Two diabetes medications, Empagliflozin and an insulin nasal spray, showed promise in aiding memory and brain health for early Alzheimer's patients, as reported in the journal Alzheimer’s & Dementia.
- Empagliflozin significantly lowered levels of tau, a toxic protein linked to Alzheimer’s disease, according to researchers.
- Researchers believe these treatments can provide therapeutic potential alone or with other Alzheimer's therapies.
- Both drugs are FDA-approved for diabetes, allowing quicker access for patients experiencing brain decline than new drugs would permit.
Insights by Ground AI
22 Articles
22 Articles
Diabetes Drugs Might Counter Brain Decline In Early Alzheimer's Patients
·New York, United States
Read Full Article
Coverage Details
Total News Sources22
Leaning Left5Leaning Right5Center3Last UpdatedBias Distribution39% Left, 38% Right
Bias Distribution
- 39% of the sources lean Left, 38% of the sources lean Right
39% Left
L 39%
C 23%
R 38%
Factuality
To view factuality data please Upgrade to Premium
